Anti-human CCL24 monoclonal antibody (CM-101)
CM-101-PSC-101
Phase 2 mab active
Quick answer
Anti-human CCL24 monoclonal antibody (CM-101) for Primary Sclerosing Cholangitis is a Phase 2 program (mab) at Chemomab Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chemomab Therapeutics
- Indication
- Primary Sclerosing Cholangitis
- Phase
- Phase 2
- Modality
- mab
- Status
- active